Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Singular Genomics Systems Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Singular Genomics Systems Inc market cap is $50.77M.
What is the 52-week high for Singular Genomics Systems Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Singular Genomics Systems Inc 52 week high is $23.41 as of September 17, 2025.
What is the 52-week low for Singular Genomics Systems Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Singular Genomics Systems Inc 52 week low is $5.34 as of September 17, 2025.
What is Singular Genomics Systems Inc stock price today?
Singular Genomics Systems Inc stock price today is $20.01.
What was Singular Genomics Systems Inc stock price yesterday?
Singular Genomics Systems Inc stock price yesterday was $19.96.
What is the PE ratio of Singular Genomics Systems Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Singular Genomics Systems Inc’s P/E ratio is -0.57.
What is the Price-to-Book ratio of Singular Genomics Systems Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Singular Genomics Systems Inc P/B ratio is 0.4070.
What is the 50-day moving average of Singular Genomics Systems Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Singular Genomics Systems Inc 50-day moving average is $20.00.
